Limit Value -time-weighted average (TLV-TWA) for toluene diisocyanate (TDI) from 5 ppb to 1 ppb, and the 15-min short-term exposure limit (STEL) from 20 ppb to 5 ppb. We evaluated ACGIH's basis for lowering these values. It is our opinion that the ACGIH's evaluation of the evidence for occupational asthma and respiratory effects from TDI exposure does not fully integrate the results of all the available human and animal studies. We found that some studies reported occupational asthma cases at TWAs less than 5 ppb, but these cases were likely caused by peak exposures above 20 ppb. Advances in industrial hygiene have reduced peak exposures and the incidence of upset conditions, such as spills and accidents, in modern TDI facilities. Taken together, the human evidence indicates that adherence to the previous 8-hr TLV-TWA and 15-min STEL (5 ppb and 20 ppb, respectively) prevents most, if not all, cases of occupational asthma, and eliminates or reduces the risk of lung function decrements and other respiratory effects. While limited, the animal literature supports the human evidence and indicates that TDI-induced asthma is a threshold phenomenon. We conclude that ACGIH's decision to lower the TLV-TWA and STEL values for TDI is not adequately supported.
Introduction
Toluene diisocyanate (TDI) is an organic compound that is used to synthesize polyurethane foams. It has two isomers that are used commercially: 2,4-TDI (CAS: 584-84-9) and 2,6-TDI (CAS: 91-08-7). While most of the diisocyanate industry uses a mixture with a ratio of 80:20 for 2,4-TDI to 2,6-TDI, other commercial mixtures are available. TDI is an occupational allergen, or sensitizer, for which the two isomers appear to be of a similar potency (Shiotsuka et al., 2000) . A sensitizer is a chemical that causes a substantial proportion of exposed people or animals to develop an allergic reaction after repeated exposure to it. The condition of being sensitized to a chemical is also called chemical hypersensitivity (OSHA, 2016) . With proper precautions, however, TDI does not pose an appreciable risk of occupational asthma (OA) to workers.
The American Conference of Governmental Industrial Hygienists (ACGIH) is a non-governmental organization that assesses industrial hygiene health and safety issues and provides scientific guidance for government, academia, and corporate facilities. One of its primary tasks is developing Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) for use in workplace exposure monitoring. TLVs are airborne concentrations of chemical substances to which nearly all workers can be repeatedly exposed, day after day over a working lifetime, without adverse health effects (ACGIH, 2016) . ACGIH derives TLV -time-weighted averages (TLV-TWAs) to protect against long-term exposures and short-term exposure limits (STELs) to protect against peaks in exposure. TLVs are not intended to represent fine lines between safe and unsafe exposures, but rather are intended to protect typical workers from adverse health effects. TLVs are based solely on health factors, and ACGIH acknowledges that it may not be economically or technically feasible to meet established TLVs or BEIs. ACGIH has developed TLVs for more than 700 chemicals, including TDI.
Non-allergenic chemicals each generally exhibit a no observed adverse effect level (NOAEL) or no observable adverse effect concentration (NOAEC), either of which can be used as the basis for a TLV. There is some support for the assertion that all sensitizers also have thresholds for an allergic response (see, for example, Cochrane et al., 2015; Dotson et al., 2015) . However, the exact mechanisms and the exposure level associated with the threshold response can vary based on the conditions of exposure (particularly the level of "peak" exposures), individual susceptibility, and other potentially unknown factors, which can make the threshold difficult to determine (Dotson et al., 2015; ECETOC, 2017) . Prevention of sensitization in naïve individuals, rather than elicitation in previously sensitized people, is generally considered the more appropriate and protective health endpoint upon which to base an occupational exposure limit (OEL) (Dotson et al., 2015) . While the derivation of STELs (protective of peak exposures) can be difficult for occupational allergens due to a lack of data (Dotson et al., 2015) , it is generally thought that acute, peak exposures are important in the development of TDI-induced allergic OA (Ott et al., 2003; Sastre et al., 2003) .
ACGIH developed its first TLV-TWA for TDI in 1959; since that time, the TLV-TWA and associated STELs have been revised numerous times. In 1959, the first TLV-TWA for the 2,4-TDI isomer was set at 100 parts per billion (ppb); it was quickly lowered to 20 ppb in 1961. From 1983 to 1998, the TLVs for 2,4-TDI were 5 ppb as an 8-hr TWA concentration and 20 ppb as a 15-min STEL. In 1998, the TLV-TWA was revised to include both the 2,4-TDI and 2,6-TDI isomers (individually or as a mixture). In 2006, ACGIH proposed lowering the 8-hr TLV-TWA and STEL to 1 ppb and 3 ppb, respectively. In 2015, ACGIH revised the proposal to an 8-hr TLV-TWA of 1 ppb and a STEL of 5 ppb; these limits were adopted in 2016 (ACGIH, 2016) .
Below, we critique the methodology used by ACGIH to develop the current TLVs, including its interpretation of the evidence. We found that the methodology is unclear, as the revised TLVs do not appear to be based on any specific study or calculation. Also, while previous, substantial reductions in workplace TWAs led to a reduction in OA cases, particularly after 1980, ACGIH did not consider that the evidence indicates that maintenance of 8-hr average TDI TWA concentrations less than or equal to 5 ppb (i.e., the previous 8-hr TLV-TWA) will result in very few, if any, new cases of OA. Our review of the evidence suggests that facilities maintaining previous TLVs have little risk of new cases of OA in their workers.
Human evidence
In the 1950s and 1960s, TWAs in TDI manufacturing and polyurethane foam plants, where exposures were most often reported as an 80:20 mixture of 2,4-TDI and 2,6-TDI, were as high as 60 ppb, with peaks up to 200 ppb during leaks, spills, and other upset conditions (see Adams, 1975; as cited in ACGIH, 2016, and Porter et al., 1975) . By the 1970s, average airborne TDI concentrations had lowered substantially, mainly because of process controls and other technological advances. At that time, TWAs generally ranged from 1 to 10 ppb in TDI manufacturing units and 5 ppb in foam production units; peaks ranged from 20 to 40 ppb or higher (Ott et al., 2000 (Ott et al., , 2003 .
Currently, TDI TWAs are even lower. In two recent studies, many TDI measurements were below the limit of detection (LOD) or very low (0.5 μg/sample 1 [Hon et al., 2017] and 0.1 ppb [Middendorf et al., 2017] ). Hon et al. (2017) conducted an analysis of exposure over time in TDI facilities in Canada. Each sample was at least 15 min in duration, with an average of about 1-1.6 h; the maximum duration was 6 h. The authors reported a significant decrease in the risk of the TWA exceeding 5 ppb as the years progressed (i.e., early 1980s to the late 1990s) (Hon et al., 2017) ; however, other studies indicate that there is still variability across jobs and across different plants. For example, Brzeznicki and Bonczarowska (2015) surveyed polyurethane foam plants between 2002 and 2012 and reported maximum TDI-TWAs that ranged from less than the limit of quantitation (0.02 ppb) to 8 ppb among departments in one plant, while in another plant, the highest TDI TWA concentration in any area was 1.8 ppb. Similarly, in a study with over 2300 TWA and peak samples across three US TDI plants, Middendorf et al. (2017) reported that mean and 95th percentile TWAs did not exceed 5 ppb in one plant, but some mean and 95th percentile TWAs were above 5 ppb in specific areas of two other plants. Similarly, there were no exceedances of the STEL at one plant, but there were some exceedances in other plants, but only in specific job types (field operators and those working in loading). Despite the documented peak exposures, across all TWA measurements, however, the average was only 0.65 ppb. The respiratory effects of occupational exposure to TDI have been extensively assessed in epidemiology studies. Many of the available studies are cross-sectional surveys (i.e., disease and exposure were measured at one point in time), but there are also a few key longitudinal studies (i.e., workers were followed over time). The most commonly reported effects in these studies are irritation (e.g., of the eyes and nose), lung function decrements, and new-onset OA or exacerbation of existing OA. These studies showed that new cases of OA and other respiratory effects in TDI workers have declined substantially over time as the typical concentrations of airborne TDI have decreased (Ott et al., 2003) . While the bases for the TLVs are OA, lung function decrements, and eye irritation, it appears that ACGIH relied most heavily on the studies of respiratory sensitization/OA (ACGIH, 2016) .
Below, we critique ACGIH's interpretation of the available epidemiology evidence and compare it to our evaluation of the exposure concentrations and conditions associated with OA in TDI-exposed workers. Inter-and intra-individual variability in health and immune status preclude the identification of universally protective exposure levels in previously sensitized individuals. In addition, the available evidence more readily supports a threshold for induction (i.e., new cases in workers not previously sensitized to TDI). Thus, our review specifically focuses on OA induction and the potential factors associated with recent declines in OA, as well as the association between TDI and lung function decrements. We focus on studies published since the TLVs were last reviewed in 2004, as well as longitudinal and other key studies that ACGIH cited in the documentation used to support lowering the TDI TLV-TWA in 2016. In contrast to ACGIH, we found that the human evidence does not support that the revised, lower TWA will result in a lower risk of new cases of OA or other respiratory effects.
Respiratory sensitization
The incidence of TDI-associated OA has declined substantially since the 1950s; longitudinal studies indicate that the rate was likely under 1% starting in the mid-1970s and has more definitively been < 1% since the 1980s (Ott et al., 2003) . While it is difficult to determine the exact exposure scenarios required to induce or elicit OA from TDI exposure, the available studies demonstrate that peak exposures above the current STEL (20 ppb) are critical, even in workplaces with relatively low TDI 8-hr TWA concentrations. Older studies (e.g., workers exposed in the 1960s-1980s) were more likely affected by very high peak exposures resulting from the more frequent occurrence of upset conditions, inadequate ventilation, and fewer other process controls. By contrast, while there may be short-term peaks in TDI concentrations in modern-day facilities, peaks are often much lower than the peaks that were greater than 20 ppb commonly reported in historical operations that have been more strongly associated with new cases of OA (Gui et al., 2014) . It is important to consider that while TWAs are affected by peak exposures, the impact of these peaks is diluted. This is because, while TWA concentrations of a chemical are effectively raised by peak exposures, the magnitude of these peaks are effectively "dampened" due to averaging (ACGIH, 2017) . Further, interindividual variability in exposure (TWAs and peaks) is particularly apparent in some of these studies. Thus, using TWAs to generalize exposure across individuals with widely varying exposure levels cannot provide information on the risk of OA at specific TWAs and peak exposures.
In its 2016 documentation, ACGIH indicated that several studies support the position that the new TDI TLV-TWA of 1 ppb and STEL of 5 ppb would further reduce the incidence of OA and associated respiratory effects, but it did not include several other available studies and did not fully and accurately represent those that it did include. For example, ACGIH cited the cross-sectional study by Littorin et al. (2007) as support for TDI-induced respiratory effects possibly associated with asthma (e.g., wheeze) at concentrations under 1 ppb, but ACGIH underreported the exposures in this study, which were generally about 2.5 ppb and as high as 5 ppb personal 8-hr TWAs (see Sennbro et al., 2004 , who reported more detailed area and personal measurements). More importantly, this study did not collect data on new physiciandiagnosed, workplace-specific cases of asthma.
In addition, ACGIH cited the Ott et al. (2000) study as evidence that the annual incidence of TDI-induced OA has decreased as TWA and peak TDI concentrations have decreased in the workplace, but it did not discuss how the results of this study inform the question of what TDI TWA and peak exposure levels are most likely associated with an increased risk of OA (ACGIH, 2016). As discussed below, Ott et al. (2000) suggested that peak concentrations greater than 20 ppb were associated with an increase in respiratory effects. Similarly, ACGIH cited the study by Weill et al. (1981) 2 in several general statements about declining rates of OA over time. However, ACGIH neither discussed the specifics of the study results, nor used these studies to reach its own conclusions on the concentration-response relationship between TDI (either peak or TWA exposures) and OA. The results by Weill et al. (1979 Weill et al. ( , 1981 suggest that most, if not all, cases of OA were associated with peak exposures, often above 20 ppb. It is notable that all of these studies were available before the 2004 ACGIH review of TDI and, as discussed below, none of the studies published after 2004 indicate that there was a risk of new-onset OA below the previous TDI TLV-TWA and STEL values (5 ppb and 20 ppb, respectively).
Review of key studies published before (2004
Numerous studies have evaluated the association between occupational exposure to TDI and OA. Because longitudinal studies are more informative in terms of the importance of peak versus cumulative exposures and trends in OA over time, these studies are the focus of this review. Overall, these studies suggest that OA is significantly increased only in workers exposed to TDI at TWAs greater than 5 ppb, and the risk of OA is likely increased only in the presence of peak exposures greater than 20 ppb. Ott et al. (2000) conducted an 18-year longitudinal study of workers in a TDI production unit in the US. The authors reported that over the study period, the incidence of OA dropped from 1.8% (1979 and earlier) to 0.7% (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) (1988) (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) . The 8-hr TWA concentrations (measured using area samples until 1976, then personal paper-tape measures thereafter) declined from 9.9 ppb to less than 1 ppb over the course of the operation of the TDI plant , though there was some variability between jobs. Peaks as high as 80 ppb were reported in several areas of the plant in the earlier years (through about 1976). The majority of OA cases (11 of 19) first reported symptoms prior to 1980 and were in the moderate-or high-exposure groups, which had average 8-hr TWA concentrations of about 6 ppb and 10 ppb, respectively. Seven of the nineteen cases reported previous incidents of potential high exposure to TDI (e.g., direct handling loading); more specifically, several cases were operators who were assigned to tanker loading (a job with measured area concentrations of 60-80 ppb TDI) at the time of symptom onset. The frequency of peak concentrations greater than 20 ppb and visits to the medical dispensary also declined over the 18-year follow-up period. From 1967 to 1985, there were 20.5, 10.9, and 3.6 dispensary visits related to TDI per 100 work-years in the jobs with potentially high, moderate, and low exposure, respectively. After 1985, the corresponding rates were 4.6, 4.9, and 1.0 incidents per 100 workyears in these same jobs. Peak concentrations greater than 20 ppb were positively associated with rates of visits to the medical dispensary, supporting the likely importance of peak exposures and upset conditions. Overall, the results suggest that cases of OA in this cohort were mainly associated with historical exposure conditions (higher TWAs and peak TDI exposures) and occurred among employees reporting previous incidents of elevated exposure to TDI (e.g., loading). Weill et al. (1979 Weill et al. ( , 1981 conducted a prospective longitudinal study of the onset and progression of TDI-induced OA. The authors collected more than 2000 personal samples of TDI over the study period, and the 8-hr averages of TDI ranged from about 0.1 to 25 ppb. A total of 12 out of 277 workers (4.3%) became "clinically sensitized" over the 5-year period, which is equivalent to an average OA incidence of 0.9% per year.
3 The authors estimated time spent above 20 ppb (peak exposures) based on personal monitoring but did not analyze the association between peak exposures and incidence of OA. However, based on job titles, Weill et al. (1979) reported that most of the workers who developed OA were exposed to peaks above 20 ppb for at least 5% of their time working, and at least another 5% of their time was spent at air concentrations between 40 and 80 ppb. More importantly, 6 of the 12 OA cases had experienced exposure to TDI during spills. Further, as reported by Ott et al. (2003) , in the 12 individuals with OA, about 50% of the time, short-term TDI concentrations exceeded 20 ppb for 7-24 min per workday. Another critical, longitudinal TDI study is the retrospective study conducted by Porter et al. (1975) of 300 people employed in a TDI plant. Over the 17-year study period (1957 through the end of 1974), 30 people were sensitized to TDI (as determined by physical examination, TDI challenge and serum TDI antibody evaluation, and pulmonary function testing following clinical protocols for diagnosing sensitization). Airborne TDI concentrations averaged 60 ppb (grab and continuous samples) from the opening of the plant in 1957 to about 1970. After 1970, average airborne TDI decreased steadily. At the time of publication in 1975, the average TDI concentration was less than 4 ppb. The average annual OA incidence rate dropped from 1.6% near the beginning of the study to 0.3% in 1973. No new cases were reported between 1972 and 1975, when TWA concentrations were between 4 and 20 ppb. Peak TDI values of up to 200 ppb were noted on 35 occasions over the 17 years (but most notably in the earlier years) and were associated with tank leaks, spills, and losses in reaction control. The authors noted that even before average TDI values decreased, the plant was better able to control peak exposures, and in the same period, cases of sensitization were reduced (Porter et al., 1975) . Karol (1981) conducted a large longitudinal screening program in workers hired in 1979 and 1980 at a facility with potential diisocyanate exposure for at least 10% of their employment, with exposure durations of 6-24 months. Serum antibody measurements were taken at baseline and throughout employment at 6-month intervals. The author found that 20 workers with higher acute exposures resulting from upset conditions (e.g., large spills, accidental direct contact via spraying of the face) had markers of sensitization in the form of increased tolyl-reactive immunoglobulin E (IgE) antibodies and associated pulmonary function decrements, while 96 others with lower exposures under normal contemporaneous exposure conditions (TWA of 20 ppb, the TLV-TWA at the time of the study) showed no respiratory symptoms or tolyl-reactive antibodies.
While the lack of standardized methods for IgE measurement and uncertainty over the accuracy of antibody detection presents challenges with interpreting Karol (1981) (Karol et al., 1994) , the longitudinal nature of the survey; the combined use of respiratory function, symptomology, and IgE testing; the relatively large population; and the replication of the findings in later studies (e.g., Karol et al., 1994) lend support to the validity of the results.
Review of key studies published since the 2004 ACGIH review
In addition to the key longitudinal studies, we evaluated five studies that have been published since the 2004 ACGIH review, three of which are included in the 2016 ACGIH documentation. Overall, the results of these studies are consistent with the results of previous studies, i.e., they indicate that an 8-hr TWA exposure of 5 ppb and STEL of 20 ppb are not likely to increase the risk of OA incidence. Three of these studiesVandenplas et al. (2011), Buyantseva et al. (2011), and Littorin et al. (2007) -are cross-sectional surveys and two -Gui et al. (2014) and Collins et al. (2017) -are cohort studies. Like all cross-sectional studies, the three cross-sectional analyses are limited because exposure and disease were assessed concurrently, and it is not possible to determine if then-current exposure conditions were representative of exposure at the time of disease onset. The cohort studies do not have this limitation. Vandenplas et al. (2011) reported a downward trend in OA between 1993 and 2002 in workers exposed to diisocyanates in Belgium. This study did not differentiate between exposure to different diisocyanates, and the potential for co-exposures was not assessed. No quantitative exposure data were reported, although the authors suggested that reduced exposure may have been responsible for the decline. Similarly, Buyantseva et al. (2011) conducted a 5-year retrospective study of workplace OA claims in Canada and reported decreasing OA claims related to diisocyanate exposure, but the authors provided no quantitative exposure estimates. Littorin et al. (2007) conducted a cross-sectional study and found increased eye and upper respiratory symptoms (e.g., wheeze, dry cough) in TDI-exposed workers compared to the unexposed workers (in industries without isocyanate, polyurethane, or other plastics exposure). However, the authors also reported decreased asthma and bronchitis and noted that exposures to dust and organic solvents could not be ruled out as confounding factors. Asthma cases were identified using medical records, and it was likely this included non-work-related asthma, because workers with isocyanate-induced asthma are excluded from continuing work in Sweden. As such, this study provides little information on new cases of isocyanate-induced asthma. Setting this aside, personal sampling showed TWAs that were as high as about 4 ppb for the 2,6-TDI isomer and up to 2.6 ppb for the 2,4-TDI isomer; thus, the total 8-hr TWAs for both concentrations may have exceeded 5 ppb. The authors did not provide information on peak exposures.
Another recent study conducted by Gui et al. (2014) , though available at the time of the ACGIH review, was not included in ACGIH's evaluation. Gui et al. (2014) assessed airborne TDI levels by fixed-point air sampling at a newly built TDI plant in Eastern Europe and evaluated respiratory health in a cohort of 49 TDI-naïve workers. Most measurements of TDI concentrations were below the LOD (0.1 ppb), and most occasional peak concentrations were below 5 ppb. The maximum TDI concentration, recorded in the foaming hall, was 10 ppb, which is above the revised STEL of 5 ppb.
With 1 year of follow-up and considerable loss to follow-up (24.5%), Gui et al. (2014) reported a few incident cases of asthma-like symptoms, TDI-specific immunoglobulin G (IgG), and forced expiratory volume in 1 s (FEV 1 ) decline > 15%, but no confirmed cases of OA. It should be noted that serum TDI-specific antigens are only found in small groups of TDI workers and, as such, are not a particularly useful indicator of sensitization (Karol et al., 1994) . Also, subjective symptoms are not informative for diagnosing OA in the absence of provocation challenge tests, lung function measures, or other clinical diagnostic tests (Reddel et al., 2009 ); many workers report symptoms of asthma but do not have evidence of asthma in functional tests (Vandenplas et al., 2017) . Despite the limitations, the study by Gui et al. (2014) provides some information regarding the lack of OA risk at a very low TDI TWA. It is unclear why ACGIH did not include this study in its evaluation.
After the ACGIH documentation was released, Collins et al. (2017) published an evaluation of TDI-induced asthma through a surveillance program at three TDI production plants in the US. Enrollment and data collection were conducted between June 2007 and June 2012. Workers with asthma symptoms or that had spirometry results that showed an FEV 1 decline of 10% or more in any 12-month period were referred to the consulting pulmonologist, who made a determination of asthma status based on the occupational exposure and medical information available. Exposure data were collected and reported in a companion paper by Middendorf et al. (2017) . Middendorf et al. (2017) reported that TWAs ranged from 0.001 to 92 ppb (measured via personal sampling of the breathing zone), although the geometric mean was 0.65 ppb. Many short-term peak concentrations exceeded the STEL value of 20 ppb. Maximum measured short-term peak exposures were 19 ppb in one plant, 200 ppb in a second plant, and 1726 ppb in a third plant. However, Collins et al. (2017) indicated that because the high exposure potential tasks were not collected in sufficient numbers, they could not make estimates of peak exposures for their analysis. Rather, they used 95th percentiles of the TWA as surrogates for peaks, which ranged from 0.01 to 19.2 ppb. Note, however, that based on the reported peaks, these 95th percentiles would be expected to underestimate the actual peak exposures for some or all cases, potentially by several orders of magnitude. The authors reported seven cases of TDI-induced asthma over the study period (there were two other cases with "indeterminate" status regarding work-relatedness) and noted that all seven cases reported detecting an odor of TDI or being in the area of a TDI release. Odor thresholds can vary from person-to-person, and studies have reported TDI odor thresholds ranging from 20 to 2000 ppb (Murnane et al., 2013) . The odds of asthma associated with each log part per billion increase in 95th percentile TWA was 1.18 (95% confidence interval [CI]: 1.06-1.32). Overall, while this analysis was limited in its ability to relate quantitative estimates of actual peak exposures and risk of OA, it supports that individual exposures to TDI releases or odors (associated with exposure to an air concentration of at least 20 ppb) are associated with the risk of OA.
Overall, in contrast to ACGIH, we found that the studies of respiratory sensitization indicate that new cases of OA are not likely to occur if plants are in compliance with TDI TWAs of 5 ppb and maximum peak concentrations of 20 ppb; thus, there is no evidence to show that lowering the TLVs would further reduce the risk of OA.
Lung function
ACGIH (2016) noted that decreases in FEV 1 can occur after both acute and chronic exposure, and can occur independent of OA. While the ACGIH documentation notes a "lack of agreement" across studies of lung function in workers, it cited several articles that observed lung function decrements at TDI concentrations as low as 2-3 ppb TDI (ACGIH, 2016). Indeed, some studies published prior to the 2004 ACGIH TDI review reported lung function declines after exposure to TDI, but this has not been shown consistently across studies, particularly at 8-hr TWA concentrations at or below 5 ppb. The evidence also indicates that peaks below 20 ppb are unlikely to result in statistically or clinically significant lung function declines. Overall, it is unlikely that low exposures lead to clinically significant decrements in lung function in non-sensitized workers. Continued exposure may be associated with lung function declines in sensitized workers, but there is some evidence of a threshold for lung function decrements even in these workers (Ott et al., 2000) . No new studies have been published since the 2004 ACGIH review.
ACGIH focused on a select group of studies to support the new TLV-TWA of 1 ppb and STEL of 5 ppb: Wegman et al. (1974 Wegman et al. ( , 1977 , both as cited in ACGIH, 2016), Wegman et al. (1982) , Diem et al. (1982) , and Ott et al. (2000) . While ACGIH (2016) noted the lack of agreement among different studies of pulmonary function effects from occupational TDI exposure, ACGIH indicated that the studies by Wegman et al.
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Regulatory Toxicology and Pharmacology 97 (2018 ) 189-196 (1974 , 1977 , both as cited in ACGIH, 2016 and Ott et al. (2003) support a TLV-TWA of 1 ppb and a STEL of 5 ppb. However, ACGIH only reported effects below 5 ppb, as an average, for one of these studies (Wegman et al., 1974; as cited in ACGIH, 2016) , and as indicated below, the study findings were, in actuality, unable to support this assertion. Overall, our critical review of these studies, below, indicates that a TLV-TWA of 1 ppb and STEL of 5 ppb are not needed to protect against lung function decrements.
Review of key studies
Wegman et al. conducted a series of studies of the same group of workers in a polyurethane manufacturing plant (Wegman et al., 1974 , 1977 , both as cited in ACGIH, 2016 . ACGIH noted that these workers experienced FEV 1 decrements at TDI exposures as low as 2-3 ppb; however, the authors did not provide averages or TWAs, and the highest exposure level was well above 2-3 ppb.
The final Wegman et al. study assessed subjective upper and lower respiratory symptomology, chronic bronchitis, atopy, and pulmonary function as measured by FEV 1 in 37 workers after 4 years of follow-up (Wegman et al., 1982) . TDI TWA concentrations were not provided, but concentrations measured as area samples ranged from "0" (presumably non-detect) to 40 ppb (reported in the mixing and pouring group of workers). Note, however, that these ranges were based on only 138 air samples collected across all exposure groups and all 4 years of the study. The authors assessed acute changes in FEV 1 as measured before and after shifts, and over the 4-year period. When stratified by smoking and exposure group, only non-smokers (n = 3) and former smokers (n = 1) in the high-exposure group experienced FEV 1 declines. This group had an average exposure of " > 3.5 ppb," but as noted above, the maximum reported TDI concentration was 40 ppb. All current smokers (n = 20) experienced declines in FEV 1 , but the response was greater in the medium-exposure group relative to the high-exposure group. The authors reported an average annual decline in FEV 1 of 60 mL in the high-exposure group, unadjusted for age and smoking status. The authors considered this decline to be above the normal yearly decline in healthy populations (32-47 mL).
The use of "average" mL FEV 1 declines across 4 years of data for 37 people is not likely an accurate measure of lung function changes. Generally, it is only possible to derive reliable estimates of FEV 1 in large groups using sophisticated statistical techniques. The short-and medium-term variability of FEV 1 in patients is so large that one would need about 10 years of data to reliably estimate the rate of decline in an individual (Hnizdo et al., 2007) . Even if the results were accurate, previous studies have indicated that absolute longitudinal values are less valid and practical in comparison to relative declines, which adjust for gender and some aspects of within-person variability. Diem et al. (1982) also reported declines in FEV 1 in non-smoking workers. Personal sampling indicated that the low-exposure group was exposed to an average 8-hr TDI TWA concentration of 1.9 ppb, but the maximum 8-hr TWA in this exposure group was 25 ppb. No declines were reported in workers who spent 98% of their time below a TDI TWA of 5 ppb. The authors recognized the likely influence of peak exposures and conducted a sensitivity analysis that showed that FEV 1 declines were significantly greater in those who had more time exposed to greater than 20 ppb relative to those who spent less time above a concentration of 20 ppb TDI. These results suggest that a TDI TWA of 5 ppb and a STEL of 20 ppb would be protective of lung function effects.
The study by Olsen et al. (1989) , which was not discussed by ACGIH in the 2016 documentation, evaluated asymptomatic lung function decrements in workers in a TDI manufacturing facility that opened in 1976 and was operating with best practices at the time of study initiation. Workers were followed for between 1 and 9 years of employment (average of ∼4 years). The authors assessed 57 workers with TDI exposure and 89 with no known exposure for lung function decrements. Routine measurements (presumed, but not confirmed as area sampling) indicated that TDI TWA concentrations were below 5 ppb, and shortterm peaks averaged 20 ppb. TDI-exposed workers were grouped into low-, moderate-, and high-exposure groups based on past and current department assignments and duration in each job. The authors tested current exposure, highest career level, cumulative exposure, and cumulative highest-to-date exposure. The authors also stratified analyses by smoking status (non-smoker, former smoker, or current smoker). The incidence of upper and lower respiratory symptoms and mean percent predicted FEV 1 were not substantially different in exposed workers relative to controls (all groups of non-smokers had FEV 1 ≥ 99% predicted) across all the measures of exposure.
As described in the previous section, Ott et al. (2000) conducted an 18-year longitudinal study in which the TDI 8-hr TWA concentrations decreased from 9.9 ppb to less than 1 ppb between 1967 and 1992. The authors reported no accelerated average annual FEV 1 or forced vital capacity (FVC) loss among employees exposed to 8-hr TWA concentrations of up to 5 ppb, including workers with OA. In the Ott et al. (2003) review, the authors re-stated the results of the Ott et al. (2000) study.
Based on our review of the key studies of TDI and lung function effects, it is clear that the ACGIH documentation does not represent the weight of the evidence for pulmonary effects from TDI exposure and therefore does not support the argument that lung function effects occur below a 5 ppb TWA and 20 ppb STEL. Although Wegman et al. (1974 , as cited in ACGIH, 2016 was hampered by limited monitoring data, this study indicates that TDI exposure peaks as high as 40 ppb may have been responsible for lung function changes. Also, Ott (2002) and Ott et al. (2003) provide evidence that longitudinal studies support a lack of lung function decrements below a TLV-TWA of 5 ppb and a STEL of 20 ppb.
Conclusions regarding human evidence
ACGIH did not address the full weight of the evidence when evaluating the association between TDI and respiratory effects in human studies (ACGIH, 2016) . ACGIH cited many of the available studies in its documentation but provided incomplete descriptions, and it is our opinion that, in some cases, it misinterpreted or misreported the results (e.g., Littorin et al., 2007; Wegman et al., 1974; as cited in ACGIH, 2016) . Of particular importance is the lack of consideration of the exposure characterization methods in the older studies and the impact of spills, accidents, and other peak exposure conditions on the interpretation of the exposure-response relationship between TDI and OA. Based on our qualitative review of studies in which these data were collected and could be linked to OA cases, for example, cases were very often those who worked in areas with a higher likelihood of peaks or for which peaks were explicitly reported. For example, Weill et al. (1979 Weill et al. ( , 1981 reported 12 cases of OA, and of those 12 OA cases, 6 were exposed to TDI during spills, and all OA cases experienced high peak exposures during at least some of their day, often > 20 ppb (see also the analysis of this cohort by Ott et al., 2003) . Similarly, in Karol (1981) , the 3 reported cases occurred in a subset of 20 workers with accidental spill exposure. In a more recent cohort, Collins et al. (2017) stated that all OA cases reported incidents of detecting TDI odors (likely associated with air concentrations of 20 ppb or more) or were exposed to TDI releases.
Overall, the evidence indicates that both peak and average exposures may be important in the development of new cases of OA, but that TDI TWA concentrations less than 5 ppb, with peaks less than 20 ppb, are unlikely to be associated with the induction of OA. Further, there is no consistent association between TDI and clinically relevant lung function decrements or other respiratory effects at TDI TWA concentrations at or below 5 ppb. Therefore, the previous ACGIH TDI TLVs of 5 ppb as a TWA and 20 ppb as a STEL will prevent most, if not all, new cases of OA and impaired lung function.
Animal evidence
ACGIH reviewed animal evidence for TDI respiratory sensitization, but did not discuss how this evidence informed its decision to lower the TDI TLVs (ACGIH, 2016 ). It appears that while the animal evidence was considered, it did not influence the overall conclusions of the review. Because the data are limited, and because ACGIH did not rely heavily on the animal studies, we provide only a brief summary and discussion of this evidence.
ACGIH focused on recent reviews and studies published since the TDI TLVs were last reviewed in 2004 (ACGIH, 2016 . Specifically, ACGIH cited a review by Schupp and Collins (2012) that reported NOAECs for respiratory sensitization (induction or elicitation) across species (including humans) ranging from 5 to 30 ppb and lowest observable adverse effect concentrations (LOAECs) ranging from 20 to 400 ppb. ACGIH also identified three peer-reviewed studies published since the previous TDI TLV values were derived, including a study of respiratory sensitization development in rats (Pauluhn, 2014) and a study of non-specific airway hyperresponsiveness (AHR) in mice after dermal TDI sensitization (Selgrade et al., 2006) . Although no animal model has been validated for quantitative risk assessment of respiratory sensitizers (North et al., 2016) , these studies can be useful for hazard identification and understanding the mechanism(s) of action.
Most notable of the cited peer-reviewed studies is that by Pauluhn (2014) , who used the Brown Norway rat 4 to test the hypothesis that occupational dermal sensitization to TDI can result in OA with subsequent inhalation exposure. In this study, rats were sensitized by dermal TDI exposures, boosted by several inhalation exposures to 12,000 ppb (83 mg/m 3 ) TDI, and then challenged with 12,000 ppb TDI for either 10, 30, or 60 min. Although the study authors indicated that they induced sensitization primarily via the dermal route, repeated "boosting" with 12,000 ppb TDI by inhalation appeared to be required in order to sensitize the rats. Evidence of sensitization (neutrophilia) appeared to be duration-dependent, being most prominent after the 60-min challenge. Pauluhn (2014) derived an OEL based on their elicitation data, which means the OEL only applies to individuals previously diagnosed with OA. Therefore, it is not directly relevant to the ACGIH TLVs, which appear to be based on prevention of new cases (induction). Further, the Pauluhn (2014) study has some limitations (e.g., lack of corresponding data in unexposed naïve Brown Norway rats, limited temporal data). Nonetheless, it clearly demonstrates that there is a threshold for elicitation, and likely induction, of TDI-induced respiratory effects in rats.
Overall, the animal studies support the human evidence, in that they provide experimental evidence of a threshold for TDI-induced respiratory sensitization. This was acknowledged by ACGIH, which stated that the animal evidence supports thresholds for both sensitization and elicitation and noted that the NOAEC for respiratory sensitization likely ranges from 5 to 30 ppb across both humans and animals ACGIH, 2016) . Thus, while the animal evidence is insufficient to determine a specific value, it indicates that a threshold for elicitation of OA exists for TDI, and that it is a function of both the concentration and duration of exposure.
Exposure-response
We did not undertake a full quantitative exploration of the potential exposure-response relationship between average or peak TDI exposures and risk of OA. Rather, we assessed whether lowering the TLVs has resulted in protection against new-onset TDI-induced asthma based on several studies conducted in different periods with different ranges of 8-h TWA TDI concentrations (Porter et al., 1975; Weill et al., 1979 Weill et al., , 1981 Karol, 1981; Ott et al., 2000; Gui et al., 2014; Collins et al., 2017 ) (See Table 1 ). Specifically, we evaluated whether annual incidences of TDI sensitivity/TDI-induced asthma changed over time or by reported upper limits of 8-h TWA using a non-parametric trend test (Kendall's tau). We observed no trend over time (p = 0.5) or by 8-h TWA (p = 0.8). This analysis is based on a limited sample of TDI epidemiology studies and could not account for changes over time within studies (e.g., declines in TWAs over several decades of the Ott et al., [2000] study). Further, the combined impact of TWAs and peaks within each study could not be completely captured through the use of upper-limit TWAs, which may have affected the results. Still, this analysis does not provide evidence that lowering the maximum TWAs resulted in substantially reduced incidence rates of OA.
There is at least one recently published exposure-response analysis on TDI, but it has important limitations. Daniels (2018) combined seven epidemiology studies of TDI-induced OA and average airborne TDI levels to derive an OEL. As discussed in comments by Goodman et al. (2018 [Forthcoming] ), the analysis by Daniels (2018) has several methodological issues. For example, Daniels (2018) did not consider underlying study quality or include peak exposure data (when available) and used aggregated data over decades of plant operation within studies (i.e., combined data on OA incidence across several decades during which airborne concentrations declined dramatically). As discussed in Goodman et al. (2018 [Forthcoming] ), the use of an additional uncertainty factor of 10 for human sensitivity is also not warranted. Setting aside these limitations, the benchmark dose derived in the threshold dose-response analyses by Daniels (2018) (without the 10-fold uncertainty factor) is equivalent to an 8-hr TWA-equivalent OEL of 4.32 ppb, which is comparable to the previous 8-h TLV-TWA of 5 ppb.
Dermal exposure
ACGIH's evaluation focused on inhalation exposure, but it has been suggested that dermal exposure to TDI may contribute to TDI-associated health effects. Unfortunately, there is a dearth of quantitative data on dermal exposures. Further, those who have attempted to quantify such exposure generally report that dermal exposure to TDI varies substantially (Boeniger, 1991; Cummings and Booth, 2002) . Another complicating factor is that personal protective equipment (PPE) usage has changed over time, and the prevalence of glove use in any given study is often unknown. Still, it is important to consider that, Note:(a) Three workers had acute exposures to TDI and antibody responses accompanied by immediate respiratory symptomology and a ≥20% decrease in FEV 1 . These findings are likely consistent with a sensitization response; however, the study authors were hesitant to make a definitive diagnosis of OA in the absence of bronchial provocation challenge with TDI.
for example, with respect to foam workers, some studies suggest that the concentration of TDI in freshly made foam declines rapidly, and there was no measureable migration from intact, cured foam (Vangronsveld et al., 2013; Arnold et al., 2012) . Further, animal studies have shown that very little dermally applied TDI is absorbed and reaches systemic circulation (< 1%) (e.g., Hoffman et al., 2010) , and that dermal exposure alone is insufficient to induce respiratory sensitization in animals. This indicates that while there remains some uncertainty, at present, the available evidence does not support that dermal exposures contribute substantially to the risk of OA in TDI workers.
Overall conclusions
It is our opinion that the ACGIH documentation for the revised TDI TLVs does not fully explain the basis for or indicate the specific evidence that it concludes supported lowering the TDI TLV-TWA concentration from 5 ppb to 1 ppb, or the TDI STEL from 20 ppb to 5 ppb. Specifically, the documentation does not fully consider or integrate the results of all the available human and animal studies. The results of the studies published between the 2004 and 2016 ACGIH reviews were similar to previous studies and thus did not indicate that the TDI TLVs should have been changed. Our analysis of the human evidence, particularly the results of longitudinal studies with sufficient exposure information, indicates that there is a threshold for the critical endpoints of OA incidence and lung function, and that the risk of these conditions is likely similarly low at the current and former TLVs. The results of historical studies that appear to support a threshold for OA induction below 5 ppb as a TWA were likely influenced by upset conditions with acute TDI concentrations well above 20 ppb. The human evidence is also supported by animal studies, which clearly indicate that there is a threshold for TDI-induced respiratory sensitization. In contrast to the conclusions of ACGIH (2016), we conclude that the evidence does not show that lowering the TDI TLVs will result in a lower incidence of OA.
